作者：
Tadashi,Hidaka [1]
;
Keiko,Imamura [2]
;
Takeshi,Hioki [3]
;
Terufumi,Takagi [4]
;
Yoshikazu,Giga [5]
;
Mi-Ho,Giga [1]
;
Yoshiteru,Nishimura [3]
;
Yoshinobu,Kawahara [1]
;
Satoru,Hayashi [6]
;
Takeshi,Niki [7]
;
Makoto,Fushimi [6]
;
Haruhisa,Inoue [7]
作者单位：
Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
[1]
Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
[2]
Takeda-CiRA Joint Program (T-CiRA), Fujisawa, Japan.
[3]
iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan.
[4]
Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan.
[5]
Graduate School of Mathematical Sciences, University of Tokyo, Tokyo, Japan.
[6]
Institute for Mathematics in Advanced Interdisciplinary Study, Sapporo, Japan.
[7]
Structured Learning Team, RIKEN Center for Advanced Intelligence Project (AIP), Fukuoka, Japan.
[8]
Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan.
[9]
DOI
10.1016/j.patter.2020.100140
PMID
33336198
发布时间
2020-12-19
换一批
换一批
